nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—SLC6A2—locus ceruleus—Parkinson's disease	0.116	0.232	CbGeAlD
Desvenlafaxine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.0918	0.184	CbGeAlD
Desvenlafaxine—SLC6A2—autonomic nervous system—Parkinson's disease	0.0617	0.124	CbGeAlD
Desvenlafaxine—SLC6A2—nerve—Parkinson's disease	0.0347	0.0695	CbGeAlD
Desvenlafaxine—SLC6A4—hindbrain—Parkinson's disease	0.0295	0.0591	CbGeAlD
Desvenlafaxine—Venlafaxine—SLC6A3—Parkinson's disease	0.0248	0.526	CrCbGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—DBH—Parkinson's disease	0.0225	0.0496	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.0202	0.0446	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—DBH—Parkinson's disease	0.0193	0.0426	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC18A2—Parkinson's disease	0.0183	0.0404	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Serotonin Transporter Activity—MAOA—Parkinson's disease	0.0182	0.0402	CbGpPWpGaD
Desvenlafaxine—SLC6A4—brainstem—Parkinson's disease	0.0169	0.0339	CbGeAlD
Desvenlafaxine—SLC6A4—forebrain—Parkinson's disease	0.0163	0.0327	CbGeAlD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—PARK7—Parkinson's disease	0.0155	0.0341	CbGpPWpGaD
Desvenlafaxine—SLC6A2—brainstem—Parkinson's disease	0.0149	0.0298	CbGeAlD
Desvenlafaxine—SLC6A2—forebrain—Parkinson's disease	0.0144	0.0288	CbGeAlD
Desvenlafaxine—Venlafaxine—CYP2D6—Parkinson's disease	0.013	0.277	CrCbGaD
Desvenlafaxine—SLC6A2—Amine compound SLC transporters—SLC18A2—Parkinson's disease	0.0127	0.028	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—ADORA2A—Parkinson's disease	0.0123	0.0272	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Parkinson's disease	0.012	0.0265	CbGpPWpGaD
Desvenlafaxine—SLC6A4—midbrain—Parkinson's disease	0.0108	0.0216	CbGeAlD
Desvenlafaxine—SLC6A2—Monoamine Transport—ADORA2A—Parkinson's disease	0.0106	0.0234	CbGpPWpGaD
Desvenlafaxine—SLC6A4—spinal cord—Parkinson's disease	0.0105	0.0211	CbGeAlD
Desvenlafaxine—SLC6A2—medulla oblongata—Parkinson's disease	0.0104	0.0208	CbGeAlD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00982	0.0217	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Synaptic Vesicle Pathway—SLC18A2—Parkinson's disease	0.00966	0.0213	CbGpPWpGaD
Desvenlafaxine—SLC6A4—head—Parkinson's disease	0.00935	0.0187	CbGeAlD
Desvenlafaxine—Venlafaxine—ABCB1—Parkinson's disease	0.00929	0.197	CrCbGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—SLC6A3—Parkinson's disease	0.0092	0.0203	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TH—Parkinson's disease	0.0092	0.0203	CbGpPWpGaD
Desvenlafaxine—SLC6A4—nervous system—Parkinson's disease	0.00886	0.0177	CbGeAlD
Desvenlafaxine—SLC6A4—Serotonin Transporter Activity—IL1B—Parkinson's disease	0.00882	0.0194	CbGpPWpGaD
Desvenlafaxine—SLC6A4—central nervous system—Parkinson's disease	0.00853	0.0171	CbGeAlD
Desvenlafaxine—SLC6A2—Amine compound SLC transporters—SLC6A3—Parkinson's disease	0.00833	0.0184	CbGpPWpGaD
Desvenlafaxine—SLC6A2—head—Parkinson's disease	0.00823	0.0165	CbGeAlD
Desvenlafaxine—SLC6A2—Monoamine Transport—SLC6A3—Parkinson's disease	0.00791	0.0174	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TH—Parkinson's disease	0.00791	0.0174	CbGpPWpGaD
Desvenlafaxine—SLC6A2—nervous system—Parkinson's disease	0.0078	0.0156	CbGeAlD
Desvenlafaxine—SLC6A2—central nervous system—Parkinson's disease	0.00751	0.015	CbGeAlD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00744	0.0164	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.0073	0.0161	CbGpPWpGaD
Desvenlafaxine—SLC6A4—brain—Parkinson's disease	0.00678	0.0136	CbGeAlD
Desvenlafaxine—SLC6A2—brain—Parkinson's disease	0.00597	0.0119	CbGeAlD
Desvenlafaxine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.00563	0.0124	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00521	0.0115	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC18A2—Parkinson's disease	0.00497	0.011	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00465	0.0102	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTA4—Parkinson's disease	0.00463	0.0102	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.00457	0.0101	CbGpPWpGaD
Desvenlafaxine—CYP3A4—nervous system—Parkinson's disease	0.00434	0.00869	CbGeAlD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00419	0.00924	CbGpPWpGaD
Desvenlafaxine—CYP3A4—central nervous system—Parkinson's disease	0.00418	0.00837	CbGeAlD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA4—Parkinson's disease	0.00398	0.00877	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00383	0.00846	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—DDC—Parkinson's disease	0.00379	0.00836	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—IL1B—Parkinson's disease	0.00375	0.00827	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.00351	0.00773	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00345	0.00761	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00337	0.00744	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.00326	0.00718	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—IL1B—Parkinson's disease	0.00323	0.00712	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00321	0.00707	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00313	0.00689	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00308	0.0068	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00301	0.00664	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00296	0.00654	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00289	0.00638	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00288	0.00635	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00285	0.00629	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.00283	0.00624	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—NQO1—Parkinson's disease	0.00277	0.00611	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HSPA1A—Parkinson's disease	0.00275	0.00607	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—SLC6A3—Parkinson's disease	0.00273	0.00602	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—Parkinson's disease	0.00272	0.006	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00264	0.00583	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00259	0.00571	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00242	0.00534	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—NQO1—Parkinson's disease	0.00238	0.00526	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—DRD1—Parkinson's disease	0.00237	0.00523	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HSPA1A—Parkinson's disease	0.00237	0.00522	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—SLC6A3—Parkinson's disease	0.00235	0.00518	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—Parkinson's disease	0.00234	0.00516	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTP1—Parkinson's disease	0.00231	0.0051	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—DRD3—Parkinson's disease	0.0023	0.00507	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HMOX1—Parkinson's disease	0.00228	0.00503	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00226	0.00498	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00219	0.00482	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00216	0.00477	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00216	0.00477	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—HGF—Parkinson's disease	0.00212	0.00468	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM1—Parkinson's disease	0.00212	0.00468	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—TH—Parkinson's disease	0.00211	0.00466	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00211	0.00465	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.0021	0.00463	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—HTR7—Parkinson's disease	0.00208	0.00458	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—DRD2—Parkinson's disease	0.00208	0.00458	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00208	0.00458	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTP1—Parkinson's disease	0.00199	0.00438	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HMOX1—Parkinson's disease	0.00196	0.00432	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00187	0.00413	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM1—Parkinson's disease	0.00183	0.00403	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—HGF—Parkinson's disease	0.00183	0.00403	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00178	0.00393	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00172	0.00379	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00165	0.00363	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00164	0.00361	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00159	0.0035	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00148	0.00326	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00146	0.00321	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00144	0.00317	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00133	0.00294	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00131	0.0029	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00118	0.0026	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.00115	0.00253	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00108	0.00238	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00106	0.00233	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00106	0.00233	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00105	0.00232	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000947	0.00209	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000934	0.00206	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000888	0.00196	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000844	0.00186	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000791	0.00174	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000767	0.00169	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000752	0.00166	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000722	0.00159	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000628	0.00138	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000627	0.00138	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000619	0.00136	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000618	0.00136	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000603	0.00133	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000573	0.00126	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000566	0.00125	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—Parkinson's disease	0.000505	0.00111	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000475	0.00105	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000473	0.00104	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000472	0.00104	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000469	0.00103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000466	0.00103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000435	0.000959	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000429	0.000945	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000308	0.00068	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000308	0.00068	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.00029	0.000639	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—OMD—Parkinson's disease	0.00029	0.000639	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000275	0.000606	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000262	0.000578	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000234	0.000515	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000234	0.000515	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000234	0.000515	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000171	0.000378	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000162	0.000357	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000146	0.000321	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000144	0.000318	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000107	0.000236	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000105	0.000232	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.81e-05	0.000216	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.7e-05	0.000214	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TH—Parkinson's disease	9.56e-05	0.000211	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.18e-05	0.000202	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—COMT—Parkinson's disease	8.13e-05	0.000179	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.09e-05	0.000178	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.07e-05	0.000178	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.98e-05	0.000176	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.66e-05	0.000169	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	7.43e-05	0.000164	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.12e-05	0.000157	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.57e-05	0.000145	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOE—Parkinson's disease	6.12e-05	0.000135	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—INS—Parkinson's disease	5.22e-05	0.000115	CbGpPWpGaD
